ORBIMED ADVISORS LLC Insider Trading for December 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ORBIMED ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of ORBIMED ADVISORS LLC for December 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 5.64 | 47 | 265 | 0 | |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 5.64 | 4,971 | 28,036 | 0 | |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 2.32 | 99 | 230 | 0 | |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 2.32 | 10,447 | 24,237 | 0 | |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 2.01 | 97 | 195 | 0 | |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 2.01 | 10,216 | 20,534 | 0 | |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 2.01 | 142 | 285 | 0 | |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 2.01 | 14,858 | 29,865 | 0 | |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 1.64 | 97 | 159 | 0 | |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 1.64 | 10,182 | 16,698 | 0 | |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 1.73 | 92 | 159 | 0 | |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 1.73 | 9,642 | 16,681 | 0 | |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 2.05 | 77 | 158 | 0 | |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 2.05 | 8,097 | 16,599 | 0 | |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 1.59 | 189 | 301 | 0 | |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 1.59 | 19,811 | 31,499 | 0 | |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 1.62 | 97 | 157 | 0 | |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 1.62 | 10,180 | 16,492 | 0 | |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 1.94 | 83 | 161 | 0 | |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 1.94 | 8,717 | 16,911 | 0 | |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 2.62 | 63 | 165 | 0 | |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 2.62 | 6,654 | 17,433 | 0 | |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 3.00 | 50 | 150 | 0 | |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 3.00 | 5,227 | 15,681 | 0 | |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 2.00 | 259 | 518 | 0 | |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 2.00 | 27,241 | 54,482 | 0 | |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 5.70 | 1,392 | 7,934 | 65,398 | 66.8 K to 65.4 K (-2.08 %) |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 5.70 | 146,243 | 833,585 | 7,194,222 | 7.3 M to 7.2 M (-1.99 %) |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 5.64 | 47 | 265 | 66,790 | 66.7 K to 66.8 K (+0.07 %) |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 5.64 | 4,971 | 28,036 | 7,340,465 | 7.3 M to 7.3 M (+0.07 %) |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 2.32 | 99 | 230 | 66,743 | 66.6 K to 66.7 K (+0.15 %) |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 2.32 | 10,447 | 24,237 | 7,335,494 | 7.3 M to 7.3 M (+0.14 %) |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 2.01 | 97 | 195 | 66,644 | 66.5 K to 66.6 K (+0.15 %) |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 2.01 | 10,216 | 20,534 | 7,325,047 | 7.3 M to 7.3 M (+0.14 %) |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 2.01 | 142 | 285 | 66,547 | 66.4 K to 66.5 K (+0.21 %) |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 2.01 | 14,858 | 29,865 | 7,314,831 | 7.3 M to 7.3 M (+0.20 %) |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 1.64 | 97 | 159 | 66,405 | 66.3 K to 66.4 K (+0.15 %) |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 1.64 | 10,182 | 16,698 | 7,299,973 | 7.3 M to 7.3 M (+0.14 %) |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 1.73 | 92 | 159 | 66,308 | 66.2 K to 66.3 K (+0.14 %) |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 1.73 | 9,642 | 16,681 | 7,289,791 | 7.3 M to 7.3 M (+0.13 %) |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 2.05 | 77 | 158 | 66,216 | 66.1 K to 66.2 K (+0.12 %) |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 2.05 | 8,097 | 16,599 | 7,280,149 | 7.3 M to 7.3 M (+0.11 %) |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 1.59 | 189 | 301 | 66,139 | 66 K to 66.1 K (+0.29 %) |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 1.59 | 19,811 | 31,499 | 7,272,052 | 7.3 M to 7.3 M (+0.27 %) |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 1.62 | 97 | 157 | 65,950 | 65.9 K to 66 K (+0.15 %) |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 1.62 | 10,180 | 16,492 | 7,252,241 | 7.2 M to 7.3 M (+0.14 %) |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 1.94 | 83 | 161 | 65,853 | 65.8 K to 65.9 K (+0.13 %) |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 1.94 | 8,717 | 16,911 | 7,242,061 | 7.2 M to 7.2 M (+0.12 %) |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 2.62 | 63 | 165 | 65,770 | 65.7 K to 65.8 K (+0.10 %) |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 2.62 | 6,654 | 17,433 | 7,233,344 | 7.2 M to 7.2 M (+0.09 %) |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 3.00 | 50 | 150 | 65,707 | 65.7 K to 65.7 K (+0.08 %) |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 3.00 | 5,227 | 15,681 | 7,226,690 | 7.2 M to 7.2 M (+0.07 %) |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 2.00 | 259 | 518 | 65,657 | 65.4 K to 65.7 K (+0.40 %) |
| Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 2.00 | 27,241 | 54,482 | 7,221,463 | 7.2 M to 7.2 M (+0.38 %) |
| Dec 12 2017 | LOXO | Loxo Oncology, Inc ... | ORBIMED ADVISORS LLC | Director | Sell | S | 82.50 | 250,000 | 20,625,000 | 941,000 | 1.2 M to 941 K (-20.99 %) |